Our Services

We serve a variety of clients ranging from global pharmaceutical companies to emerging biotech organisations.

We solve our clients’ most challenging issues, including pricing, access, value, portfolio design, launch strategy, partnership strategy, and policy development.

Decisive lift
plug-in teams

- Launching a new organisation, entering a new market or region
- Need to scale rapidly
- Limited capability
- Uncertainty and financial constraints
- Lack of infrastructure
Bringing speed, experience and expertise:
Our team within your team bringing the skill, expertise, and capability you require, when you need it
End-to-end management of pricing and reimbursement processes as a single point of contact across in-scope markets
Broad reach across countries through our Decisive team and intelligent network

Decisive valuate
strategic insight & recommendations

valuate delivers:
- Global landscape: competition, HTA, disease burden
- Asset evaluation: pricing potential and route to market
- HTA and access strategy
- Go-to-market sequencing, resourcing and JCA planning
- Planning for early access and named patient programmes (NPP)
Powerful insights and solutions
Superior insight: strong payer network blended with practical day-to-day experience
Expert analysis: insightful interpretation powered by industry experience and technical rigor, all enabled by technology
Decisive recommendations: informing your most important choices: access strategy, pricing, HTA, phase II-III clinical development

Decisive transform
upskilling teams & organisations

- Companies building access organisations that are future fit
- Established teams preparing for change (JCA)
- Teams preparing for launch and negotiation
- Departments seeking breakthrough capabilities for access
Access has fundamentally changed
Shaping for success is about creating the right capabilities, mindset, alignment and coordination
Building cutting edge internal capabilities, assessing readiness, sharing insights into industry best practice and enabling internal transformations
Preparing for critical external engagement simulating high stakes discussions with a focus on collaborative negotiation

Decisive evidence
modelling & RWE

- Early economic modelling through to full cost-effectiveness analysis
- Identifying and addressing gaps in evidence
- Planning indirect treatment comparisons from ideation to delivery
- Building powerful submissions with a clear strategy
RWE generation and modelling
Evidence driving strategy: finding the right evidence and addressing the gaps via our skilled team of writers; conducting systematic literature reviews and crafting compelling value stories told through value dossiers and local submissions
Strategy driving evidence: lifting the evidence base and utilising it to the max
Modelling: utilising health economic modelling from early decision making